In the April 15, 2015, Federal Register, FDA announced it is seeking nominations for industry representatives to serve on the public advisory committees for the Center for Drug Evaluation and Research ("CDER"). Organizations interested in helping select the nonvoting representatives should notify FDA. Interest letters and nominations are due May 15, 2015.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
